课题基金 / 基金详情

Transcriptomic analysis and validation of neuroprotective candidates for the development of innovative diagnostic and therapeutic targets in neurology

Transcriptomic analysis and validation of neuroprotective candidates for the development of innovative diagnostic and therapeutic targets in neurology
神经保护候选药物的转录组分析和验证,用于开发神经病学创新诊断和治疗靶点
批准号:
289331510
负责人:
Dr. Alexander Schulz, Ph.D.
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2017-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
这项研究计划旨在通过对受损神经元的转录组分析来确定神经保护候选者,以开发神经学中创新的诊断和治疗靶点。到目前为止,临床神经病学面临着一种公然的情况,即大多数急性和慢性中枢神经系统疾病都不能以治愈性或因果的方式治疗。重要的是,大多数神经系统疾病有一个惊人的相似之处:神经细胞的死亡是受影响个体产生功能障碍和症状的原因。这就是为什么一种解决策略是预防或至少延缓神经元死亡,而有害的刺激则会危及神经元的生存。有了对神经元如何对威胁生存的伤害做出机械反应的更好的理解,神经保护和神经学领域可能会发生积极的转变。有了对细胞命运有利和不利的信号事件的适当知识,适当的和选择性的治疗干预可能能够延长细胞存活和防止细胞死亡。来自各种预适应实验和选择性神经元脆弱性的数据已经提供了生物学证据,证明这是可以实现的。然而,对于神经元在损伤或损伤后发生的确切分子机制知之甚少。通过RNA测序进行单独的转录组分析的组合;其中三个独立的神经退行性变模型被用于确定新损伤的神经元共享的共同转录签名,这项研究提案旨在识别神经元损伤反应的关键成分和潜在的可用药靶点。为了验证从小鼠原代皮质神经元获得的测序结果,将应用线虫动物模型;利用简单和成熟的工具建立转基因动物,以及在体内进行单细胞水平的神经元损伤实验的能力。这个研究项目的显著优势是,我们已经从哺乳动物组织中进行了转录组分析,并将从进化的角度将结果后退一步。这意味着所有经过验证的神经保护候选者都会自动拥有老鼠的同源物,并可以在以后的时间点应用于哺乳动物测试系统。从长远来看,这项研究计划的目标是破译神经元损伤的基本机制,这些机制可能有助于各种神经疾病的诊断和治疗。通过在应激状态下的神经细胞(处于危险状态的神经元)中发现具有高度特异性表达的基因或蛋白质,不仅有可能为进一步的研究创造新的生物工具和动物模型,而且还可能开发出可以改善大脑疾病诊断和分期的技术。
英文摘要
This research proposal aims to identify neuroprotective candidates by transcriptome analysis of injured neurons, for the development of innovative diagnostic and therapeutic targets in neurology. To date, clinical neurology suffers from the blatant situation that the majority of both acute and chronic CNS disorders cannot be treated in a curative or causal fashion. Importantly, most neurological diseases share one striking similarity: the death of neuronal cells is what produces malfunctions and symptoms in affected individuals. This is why one solving strategy would be the prevention, or at least the delay, of neuronal death while a harmful stimulus risks the survival of neurons. Armed with a better understanding of how neurons mechanistically react to survival-threatening injuries, the field of neuroprotection and neurology could be positively transformed. With appropriate knowledge of signaling events that are beneficial and detrimental for the cell fate, appropriate and selective therapeutic interference might be able to prolong cell survival and to prevent cell death. Data from various preconditioning experiments and selective neuronal vulnerability already provide biological evidence that this is attainable. However, little is known about the exact molecular mechanism that takes place in neurons after injury or damage. By performing a combination of separate transcriptome analyses by means of RNA sequencing; where three independent models of neurodegeneration are used to determine a common transcriptomic signature shared by newly injured neurons, this research proposal aims to identify key components and potentially druggable targets of neuron damage response. To validate the sequencing results derived from murine primary cortical neurons, the animal model C. elegans will be applied; taking advantage of the easy and established tools to establish genetically modified animals and the ability to perform neuron injury experiments at the single-cell level in vivo. The striking advantage of this research project is the fact that we have performed transcriptome analysis from mammalian tissue and will transfer the results a step back in evolutionary terms. This means that all validated neuroprotective candidates automatically have a mouse homologue and can be applied in a mammalian test system at a later time point. Long-term, the goal of this research proposal is to decipher fundamental mechanisms of neuronal damage that could be useful in the diagnosis and therapy of a variety of neurological disorders. By finding genes or proteins with a highly specific expression in stressed neuronal cells (neurons at risk), it would not just be possible to create new biological tools and animal models for further research, but also to develop techniques that could improve the diagnosis and the staging of brain disorders.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1083/jcb.201807127
发表时间: 2020-01
期刊: The Journal of Cell Biology
影响因子: --
作者: [A. Schulz;Y. Sekine;Motunrayo J Oyeyemi;Alexander Abrams;Manasa Basavaraju;S. M. Han;Marco Groth;H. Morrison;S. Strittmatter;Marc Hammarlund]
通讯作者: A. Schulz;Y. Sekine;Motunrayo J Oyeyemi;Alexander Abrams;Manasa Basavaraju;S. M. Han;Marco Groth;H. Morrison;S. Strittmatter;Marc Hammarlund
国内基金
海外基金
Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    USHARANI HAREESH GOVINDARA JAN
  • 依托单位:
利用全基因组关联分析和QTL-seq发掘花生白绢病抗性分子标记
基于SERS纳米标签和光子晶体的单细胞Western Blot定量分析技术研究
  • 批准号:
    31900571
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    刘兵
  • 依托单位: